Cvs Caremark Cp (CVS)
Price: $44.91
Industry: Food/Drug-Retail/Wholesale Chaikin Power Gauge Report | Generated: Wed Feb 29 11:40 EST 2012 Power Gauge Rating
CVS - Bullish TM
The Chaikin Power Gauge Rating for CVS is bullish due to very positive expert opinions. The rating also reflects poor financial metrics. Expert opinions about CVS are very positive which is evidenced by analysts revising earnings estimates upward and a very low short interest ratio.
News Sentiment Rating
Bearish CVS Cvs Caremark ..
February 24, 2012
TM
Chaikin Sentiment Gauge for CVS is bearish. There is currently a significant negative sentiment within news stories concerning CVS.
News Sentiment :Negative
Power Trend - 5 Year Chart
The Power Gauge distills a 20 factor model into a concise picture of a stock's potential.
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
High Potential
Neutral
Low Potential
www.chaikinpowertools.com
Financials & Earnings
Financial Metrics Rating
Financial Metrics
Bearish
LT Debt/Equity Ratio
CVS's financial metrics are poor. The company has relatively low revenue per share and generates relatively low free cash flow relative to market capitalization.
Price to Book Value
The rank is based on a low price to book value, high price to sales ratio and relatively low cash flow.
Return on Equity
Price to Sales Ratio
Business Value
Assets and Liabilities
Valuation
Returns
Ratio
TTM
Ratio
TTM
Ratio
TTM
Current Ratio
1.56
Price/Book
1.54
Return on Invest
7.9%
LT Debt/Equity
0.24
Price/Sales
0.55
Return on Equity
9.9%
Earnings Performance
Earnings Performance Rating
Neutral
Earnings Growth
CVS's earnings performance has been neutral. The company has a stable 5 year earnings trend and has not met analysts' earnings estimates.
Earnings Surprise
The rank is based on worse than expected earnings in recent quarters, a relatively poor trend in earnings this year, a relatively high projected P/E ratio and consistent earnings over the past 5 years.
Earnings Trend
Projected P/E Ratio
Earnings Consistency
5 Year Revenue and Earnings Growth
Revenue(M) Rev % Growth EPS EPS % Growth
EPS Estimates
12/07
12/08
12/09
12/10
12/11
76,329.50
87,471.90
98,729.00
96,413.00
107,100.00
74.21%
14.60%
12.87%
-2.35%
11.08%
$1.98
$2.23
$2.58
$2.51
$2.59
20.00%
12.63%
15.70%
-2.71%
3.19%
EPS Surprise
Factor
Actual EPS Prev
EST EPS Current
Change
$0.52
$0.63
+0.11
Quarterly EPS Yearly EPS Factor
$2.59
$3.27
+0.68
Actual EPS Growth
Est EPS Growth
Change
22.08%
11.83%
-10.25
3-5 year EPS
EPS Quarterly Results Estimate
Actual
Difference
% Difference
FY
Qtr 1
Qtr 2
Qtr 3
Qtr 4
Total
Latest Qtr
$0.89
$0.89
$0.00
1 Qtr Ago
$0.67
$0.70
$0.03
0.00
12/09
$0.51
$0.61
$0.71
$0.75
$2.58
4.48
12/10
$0.56
$0.61
$0.59
$0.75
$2.51
2 Qtr Ago
$0.64
$0.65
3 Qtr Ago
$0.55
$0.57
$0.01
1.56
12/11
$0.52
$0.60
$0.65
$0.82
$2.59
$0.02
3.64
Fiscal Year End Month is December.
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
www.chaikinpowertools.com
Price Trend & Expert Opinions Price/Volume Activity
Price/Volume Activity Rating
Neutral
Relative Strength vs Market
Price and volume activity for CVS is neutral. CVS has outperformed the S&P 500 over 26 weeks and is in a decelerating price trend compared to 4 months ago.
Chaikin Money Flow
Price Trend
The rank for CVS is based on its price strength versus the market, positive Chaikin money flow, a positive Chaikin price trend, a negative Chaikin price trend ROC and a decreasing volume trend.
Price Trend ROC
Volume Trend
Relative Strength vs S&P500 Index
Chaikin Money Flow
Chart shows whether CVS is performing better or worse than the market.
Chaikin Money Flow analyzes supply and demand for a company's stock.
Price Activity
Price Activity
Factor
Value
Factor
52 Week High
44.91
52 Week Low
32.06
% Change YTD Rel S&P 500
-0.49%
Expert Opinions
Volume Activity Value
Factor
% Change Price - 4 Weeks
7.57%
Average Volume 20 Days
7,497,414
% Change Price - 24 Weeks
22.84%
Average Volume 90 Days
8,965,552
% Change Price - 4 Wks Rel to S&P
2.88%
% Change Price - 24 Wks Rel to S&P
5.00%
Value
Chaikin Money Flow Persistency
66%
Expert Opinions
Very Bullish
Earnings Estimate Revisions
Expert opinions about CVS are very positive. Analysts are raising their EPS estimates for CVS and shorting of CVS is low.
Short Interest
Insider Activity
The rank for CVS is based on analysts revising earnings estimates upward, a low short interest ratio, insiders purchasing stock and optimistic analyst opinions.
Analyst Opinions
Relative Strength vs Industry
Earnings Estimate Revisions Current Current Qtr Next Qtr
0.63 0.74 Current
Current FY
3.27
Analyst Recommendations
7 Days Ago % Change 0.63 0.74
0.00% 0.00%
30 Days Ago % Change 3.25
0.02
EPS Estimates Revision Summary
Factor Mean this Week Mean Last Week
Value
Strong Buy 0.00
Last 4 Weeks
Down
Up
Down
Curr Qtr
0
0
9
0
Curr Yr
1
0
12
1
Next Qtr
0
0
4
1
Next Yr
0
0
7
0
Strong Buy
Change Mean 5 Weeks Ago
Last Week Up
Strong Buy
I want to receive special offers about trading stocks with your brokerage partner, optionsXpress. Click here
www.chaikinpowertools.com
The Company & Its Competitors
News Headlines for CVS
CVS's Competitors in Food/Drug-Retail/Wholesale Company
Power Gauge
Historic EPS growth
Projected EPS growth
Profit Margin
PEG
PE
Revenue(M)
CVS
22.08%
11.83%
3.22%
1.16
15.98
107,100
MCK
4.98%
14.25%
1.09%
0.91
13.84
112,084
HLF
13.25%
14.00%
11.93%
1.33
20.14
3,455
RAD
8.85%
-
-1.62%
-
-
25,215
WAG
8.80%
12.01%
3.68%
1.05
12.61
72,184
ABC
5.59%
13.00%
0.88%
1.03
14.50
80,218
CAH
4.81%
12.82%
0.89%
1.03
14.62
102,644
PMC
16.86%
17.00%
1.12%
0.62
10.06
2,081
PuraMed BioScience@, Inc. Reports Increased Revenue From Sales of LipiGesic@ M, Its Flagship Migraine Pain Relief Product - Feb 15, 2012 CVS Caremark 4Q profit climbs nearly 4 percent - Feb 8, 2012 Sector Snap: Pharmacy benefits and drugstores - Feb 7, 2012 CVS/pharmacy Launches Enhanced "Send to Card" Digital Options for Redeeming ExtraBucksŽ Rewards - Jan 16, 2012 CVS Caremark Corporation Settles FTC Deceptive Pricing Charges - Jan 12, 2012
Company Details
Company Profile
Cvs Caremark Cp ONE CVS DR. WOONSOCKET, RI 02895 USA Phone: 4017651500 Fax: 401-762-2137 Website: http://http://www.info.cvscaremark.c om Full Time Employees: 202,000 Sector: Retail/Wholesale
CVS/Caremark is the nation's premier integrated pharmacy services provider, combining one of the nation's leading pharmaceutical services companies with the country's largest pharmacy chain. The company fills or manages more than one billion prescriptions per year, more than any other pharmacy services provider. CVS/Caremark drives value for pharmacy services customers by effectively managing pharmaceutical costs and improving healthcare outcomes through its six thousand two hundred CVS/pharmacy stores; its pharmacy benefit management, mail order and specialty pharmacy division, Caremark Pharmacy Services; its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com.
Power Gauge Ratings are created using a relative ranking system that assigns a rank of 0 to 100 (100 being the highest) to each stock in the universe. Rank is calculated by evaluating each of the stocks factors and combining them into a single number using a weighting formula. A stock's rank ranges from 100-0, where 100 is the strongest, and a rank of 95 indicates the stock is better than 95% of the stocks in the universe. Chaikin Stock Research(CSR) is not registered as a securities broker dealer or investment advisor with either the U.S. Securities and Exchange Commission or with any state securities regulatory authority. CSR is not responsible for trades executed by users of this research report, our web site or mobile app based on the information included herein. The information presented in this report does not represent a recommendation to buy or sell stocks or any financial instrument nor is it intended as an endorsement of any security or investment. The information in this report is generic by nature and is not personalized to the specific financial situation of any individual. The user bears complete responsibility for their own investment research and should seek the advice of a qualified investment professional before making any investment decisions. Copyright (c) 1978-(Present) by ZACKS Investment Research, Inc ("ZACKS"). The information, data, analyses and opinions contained herein (1) includes the confidential and proprietary information of ZACKS, (2) may not be copied or redistributed, for any purpose, (3) does not constitute investment advice offered by ZACKS, (4) are provided solely for informational purposes, and (5) are not warranted or represented to be correct, complete, accurate or timely. ZACKS shall not be responsible for investment decisions, damages or other losses resulting from, or related to, use of this information, data, analyses or opinions. Past performance is no guarantee of future performance. ZACKS is not affiliated with Chaikin Power Tools. This report from Chaikin Power Tools is for informational purposes only and is not a recommendation to buy or sell securities.
LM 2.3 DS 3.0 LS 2.1
Data Provided by ZACKS Investment Research, Inc., www.zacks.com
Special offers to trade stocks from optionsXpress: www.chaikinpowertools.com